Clinical Trial 36491

St. Louis, MO 63141


Summary:

Study 36491 Flyer
Click image to enlarge

The study is being done to see how safe a new investigational drug is and how well it might work to help people with Alzheimer's disease. The study may help answer the following research questions:

The safety of LY3202626 and any side effects a  person might have when he/she takes it.

Whether LY3202626 can help people with Alzheimer's disease

How much LY3202626 should be given to people

In addition this study will compare LY3202626 with a placebo to see if taking LY3202626 is better than taking a placebo. THe placebo is a capsule that looks like a drug buy has no drug in it. Be aware that this form refers to LY3202626 and placebo as "study drug".


Qualified Participants Must:

• Be between 55 and 85 years of age
• Have a MMSE score of between 20-26
• Have mild dementia based on the disease diagnostic criteria as determined by a qualified clinician


Qualified Participants May Receive:

Participants and their study partner will be compensated for time and travel as listed in the consent form.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.